www.heartburncanceruk.org
HEARTBURN CANCER UK
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2021
Company Registered Number: 07227937
Charity Registered Number: 1136413
14434421_1
HEARTBURN CANCER UK ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
| YEAR ENDED 30 APRIL 2021 | |
|---|---|
| CONTENTS | PAGES |
| Officers and professional advisers | 1 |
| Trustees' report | 2-7 |
| Independent examiner's report | 8 |
| Statement of financial activities | 9 |
| Balance sheet | 10 |
| Notes to the unaudited financial statements | 11 to 19 |
HEARTBURN CANCER UK ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
OFFICERS AND PROFESSIONAL ADVISERS
Trustees Mrs M E McCord Prof R C Fitzgerald Mr T Thornton-Jones Prof T J Underwood Mrs B A Huntingdon Mr P R Carr Mrs J R M Carr Business address and registered office Grove House Lutyens Close Chineham Court Basingstoke Hampshire RG24 8AG Independent Examiner Carmel Warren 22 Queens Ride Crowthorne Berkshire RG45 6LG
1
HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)
YEAR ENDED 30 APRIL 2021
The trustees present their report and the unaudited financial statements of the charitable company for the year ended 30 April 2021.
The unaudited financial statements have been prepared in accordance with the accounting policies set out in note 1 to the unaudited financial statements and comply with the charity's governing documents, The Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to small charities preparing their accounts in accordance with the Financial Reporting Standards applicable in the UK and Republic of Ireland (FRE 102)" (as amended for accounting periods commencing from 1 January 2016).
Objectives and Activities
During the fiscal year 2020-21, Heartburn Cancer UK continued to work towards our well-defined mission and objectives as follows:
Mission
To be a respected UK source of awareness and information on the risks of ignoring persistent heartburn, encouraging the public to seek medical advice, to champion research to enable an earlier diagnosis to save lives, and to support those living with reflux, Barrett’s oesophagus and oesophageal cancer .
Our Objectives
For more information please visit our website at www.heartburncanceruk.org
Public Benefit
The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.
2
HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report) (continued)
YEAR ENDED 30 APRIL 2021
Achievements and performance
The Covid-19 pandemic has had a significant negative impact on all charities across the UK and wider world over the past 12 months. This has affected both our income levels as well as our plans to undertake awareness activities, as three UK lockdowns have prevented the UK populace from undertaking what might be considered a ‘normal’ life. As a result, our FY21 projected budget was quickly deemed inappropriate in early FY21, and we have striven since then to find other and creative ways to both raise funds as well as achieve the other key objectives of the charity.
Significantly, we have found new channels for funds, and have managed to increase our income compared to the previous year, albeit in a rather different shape; our plans to grow revenue by around 50% in FY21 have, though, proved difficult given the virus.
Fundraising
-
Our tribute funds with Much Loved have worked well for people fundraising in memory of a loved one with an income of approximately £13,400 from 4 tributes.
-
Plans to raise income from sponsorship for activities has been severely curtailed as those activities (Marathons etc) were cancelled. More recently, some supporters have adopted ‘virtual’ events as a means to raise funds, but these events were slow to launch after the initial shock of lockdowns being imposed, and so have had limited impact.
-
We have been successful in attracting some medium-sized grants from various bodies which has enabled us to continue to operate for the benefit of heartburn sufferers without financial stress, and these grants, along with the other income streams, have ensured our income level in FY21 is on a par with that achieved in FY20 – a remarkable achievement considering the environment in which we have been forced to operate.
-
Our first proper venture into merchandising, using our excellent new website platform, raised just over £1,100 at Christmas from the sale of cards to the public.
-
The capability introduced with launch of the new website for online donations has seen approximately £9,500, including gift-aid, donated direct to date; this is a benefit to HCUK since the commission charged for processing is less than that charged by the likes of Just Giving and Virgin.
-
We have embarked on our first ‘official’ corporate partnership with The Lanesborough Hotel in London. Two of their staff members and the husband of one of their senior team have lost their lives to oesophago-gastric cancers. They have named HCUK as their charity of choice and have already donated Christmas gift money which their staff have collected of around £1,000. Once they have reopened following lockdown, they have various thoughts about how they might work with HCUK to raise further funds .
-
Partnerships were created with Make a difference cards, Charity Traveller, Discover Adventure and Much Loved. Much Loved have been the most successful to date. Holiday and adventure partnerships will hopefully become more relevant beyond the pandemic.
Patient Support
-
Support Groups affiliated to the charity were obviously impacted by restrictions on meeting in person. Despite this being a challenge throughout the pandemic, both London and East Anglia have continued their work, using virtual Zoom meetings.
-
We received some funding to support the set up and administration of a new Patient Support Group on Facebook (Barrett’s and Oesophageal Cancer Online Support Group), which now has over 50 members, a significant proportion of whom are active and either requesting or providing advice on coping with symptoms and treatments.
3
HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)
(continued)
YEAR ENDED 30 APRIL 2021
Achievements and performance (continued)
Research and Diagnosis
-
As the NHS re-deployed resources to cope with the enormous influx of Covid-19 patients, as well as imposing ‘clean regimes’ to prevent excess spread of the virus, services such as cancer-care were reduced and postponed. This has led to a perceived increase in the number of sufferers of heartburn who will not have been adequately diagnosed and treated; a timebomb as we defeat Covid-19 and return to a form of normality. We know that rates of endoscopy have been reduced dramatically, and inevitably this will lead to greater levels of incurable forms of the disease going forward. Endoscopic cancer detection reduced by 58% overall over a study period Jan to 31 May using the UK’s National Endoscopy Database by an NHS group.
-
HCUK has worked with the Delta team, led by Prof Rebecca Fitzgerald, involved in development of the Cytosponge’ – a diagnostic tool less invasive and less expensive than an Endoscopy – to plan for a Mobile Diagnostic Unit and 1,500 tests in mid-2021 aimed at proving its value as well as saving lives. This represents the largest single investment in a project ever made by HCUK.
The construction and fit-out of the Mobile Diagnostic Unit commissioned and funded by the charity was completed just prior to the year end and the total costs of approximately £27,000 have been capitalised in the balance sheet. Deployment of the unit on the first phase of its involvement in the Delta project took place in early May 2021. This phase of the DELTA project is planned to take several months to complete and the outcome of that project will determine what the next steps will be for the Mobile Diagnostic Unit.
General Awareness
-
Following production of our first video campaign featuring ‘Mimi’s Story’ for the Hampshire campaigns in 2019 & early 2020, this was used again in a Sky AdSmart campaign during the early summer 2020 with the objective of raising money as well as achieving awareness of the dangers of ignoring persistent heartburn. Whilst we did see 130,000 impressions delivered amongst around 35,000 individual viewers, the fundraising objective (‘text donate’) was unsuccessful.
-
Our social media presence has been the focus of 2020 into early 2021, and we’ve seen great increases in our followers, friends etc on Facebook, Twitter, LinkedIn and Instagram, with regular and informative posts. We continue to work with an external provider to ensure regular and timely Social Media output, and this is expected to continue.
-
Towards the end of the year we produced our second video, with additional audio file for radio campaigns, which takes the stories of 3 heartburn sufferers who were caught in time to save their lives, as well as the thoughts of a Specialist Research Nurse. This is the so-called ‘Happy Outcome’ campaign, to be used going forward on Social Media, Radio and possibly TV.
-
Our website redevelopment in late FY20 has provided a fabulous platform for communication, and is seeing major uplift in visitors. We continued to exploit opportunities using the site, especially online merchandising and the sale of our Christmas Cards, generously donated to us by a print partner.
-
Other planned awareness campaigns in the NW, London and Scotland were necessarily shelved given the absence of footfall in outdoor locations for viewing, in addition to a desire not to cause unnecessary worry amongst the general public as it became much more difficult and in some cases impossible to see a GP or to access an endoscopic examination in lockdown.
4
HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report) (continued)
YEAR ENDED 30 APRIL 2021
Achievements and performance (continued)
In summary, despite the challenges posed to charitable organisations around the world by the Covid 19 pandemic, HCUK has managed to sustain its income, albeit in an atypical manner, whilst investing both time and financially in the exciting Mobile Diagnostic Unit, which will be the focus of our awareness and support activity throughout FY22 and beyond. Pure awareness activity was limited in 2020 to our TV campaign as well as social media, particularly due to Covid-19 lockdowns and therefore the unsuitability of outdoor campaigns to spread our message.
Financial Review
Total reserves are £126,438 (2020: £106,302), of this £40,248 is restricted and within restricted funds are held the fixed asset balance for the Mobile Diagnostic Unit. See note 17 for the detailed descriptions and balances on these funds.
It is the policy of the charity that unrestricted funds, which have not been designated for a specific use should be maintained at a level equivalent to six months's expenditure, which is calculated to be in the region of £35,000. The Trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity's current activities whilst consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.
Risks
The Trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.
Plans for the future
Our major focus, for the forthcoming financial year to April 2022, is executing a successful Mobile Diagnostic Unit Pilot with Project Delta and maximising all opportunities for fundraising, general awareness and positive PR on this very tangible ‘make a real difference’ initiative. Leaving this new geographic area with lasting GP and Pharmacy relationships for awareness and support of the public living with reflux, Barrett’s or oesophageal cancer. We have a fantastic opportunity for new collaborations this year as a result of the work undertaken, which should make it much more straightforward to expand our messages of awareness wider in the UK.
Resources-permitting we are also planning to re-schedule the outdoor awareness campaigns shelved due to the pandemic in 2020. These are likely to be undertaken in the NW & NE of England as well as Scotland, where we know that the prevalence of undiagnosed Barrett’s and oesophageal cancer is higher than the UK average.
Meanwhile we will finalise our fundraising strategy and delivering against our plans, continue with initiatives that have worked well for us and progress new ideas as we start being released from the pandemic.
We will continue to encourage people to seek current information and guidance from our website ‘our shop window’ and encourage them to get involved to support us whenever we can. We will actively do this through all awareness activity, PR and social media. We again intend to double our social media following on all platforms in the year ahead.
We plan to maximise opportunities from our website. Our Google Adwords account will be moved to a new partner in June 2021, with the aim of enhancing our visitor numbers for support as well as fundraising.
It’s important to continue our patient support activity. Patients contact the office by phone or email or they find us on or through our more traditional support groups. We are investigating cost effective methods of developing this further, especially in instances where patients can help and advise each other from the perspective of their personal experiences. We are also ready to start new groups in areas where there is a need, most probably commencing in regions where we deploy the Mobile Diagnostic Unit.
5
HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)
(continued)
YEAR ENDED 30 APRIL 2021
Structure, governance and management
The following served as trustees during the year:
Mrs M E McCord Mr A R Cheyne OBE Prof R C Fitzgerald Mr T Thornton-Jones Prof T J Underwood Mrs B A Huntingdon Mr P R Carr Mrs J R M Carr
(deceased 8 May 2020)
The above are also Directors for the purposes of company law.
The Board have the statutory power to appoint new trustees under the terms of the Trust Deed and provide the necessary training in order that they may fulfil their obligations as Trustees.
None of the Trustees has any beneficial interest in the company. The Directors, are members of the company and guarantee to contribute £1 in the event of a winding up.
The charity is governed by the Board of Trustees which is responsible for formulating the strategies and policies of the charity including exercising financial controls.
Trustees' responsibilities
The Trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, incuding the statement of financial acitvities of the charitable company for that year. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
make judgements and estimates that are reasonable and prudent;
-
observe the methods and principles in the Charities SORP;
-
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the accounts; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.
6
HEARTBURN CANCER UK TRUSTEES. REPORT {Incorporating Directors. Report) Icontinuedl YEAR ENDED 30 APRIL 2021 The Trustees are responsible for keeping proper accounting records that are sufficient to show and explain the charitable company's transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the fiftancial statèmonts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable step5 for the prevention and detection of fraud and other irregularities. This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption. Signed on behalf of the Board of Tru5tee5 Mrs M E Mccord Chair of Trustees Approved by the board on.. io ZOZI
INDEPENDETrTh EXAMINER'S REPORT TO THE TRUSTEE5 OF HEARTBURN CANCER UK YEAR ENDED 30APRIL2021 I report on the financial statements of the chartty for the year ended 30 April 2021. which are set out on pages 9 to Ig. Respectlve responsibilities of Trustee5 and examiner The charity's Trustees, who a a150 the director5 of Heartburn Cancer UK for the purposes of company law, are responsible for the preparation of the accounts. The Trustees consider that an audit is not required for thi5 year under section 144121 of the Charities Art 2011 (the 2011 Act) and that an independent examination 15 needed. Having satisfied myself that the charity is not subject to audit under company law and is eligible for independent examination, it is my responsibility to= lil examine the financial statements under section 145 of the 2011 Act- lill to follow the procedures13id down in the general Dirertion given by the Charity Commission under section 1451Sllbl of the 2011 Act: and 11111 to state whether particular matters have come to my attention. Basis of Independent examinels report My examination was carfied out in accordance with the general Direction5 given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the financial statements presented wf(h those records. It also include5 consideration of any unusual items or disclosures in the financial statements, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence th8t would be required in an audit and consequently no opinion is given as to whether the financial statements present a 'true and fair view, and the report 15 limTted to those matters set out in the next statements. Independent examinerfs statement In connection with my examination, no matter has come to my attention-. lal which gives me reasonable cause to believe that in any material respect the requirements.. lil to keep accounting records in accordance with section 386 of the Companies Act 2006.and lill to prepare financial statements which accord with the accounting records, comply with the accounting requirements of section 396 of the companies Act 2006 and with the method5 and principle5 of the statement of Recommended Practice Accounting and Reporting by Charities; have not been met.. or Ibl to which, in my opinion. attention should be drawn in order to enable a proper understanding of the financial statements to be reached. Cam)el Warren 22 Queens Ride Crowthorne Berkshire RG45 6LG Date.. io 20zI
HEARTBURN CANCER UK STATEMENT OF FINANCIAL ACTIVITIES including INCOME AND EXPENDITURE ACCOUNT YEAR ENDED 30 APRIL 2021
| General Designated Notes Income from: Donations and legacies 2 75,148 - Fundraising activites 3 1,138 - Investments 4 41 - Total incoming resources 76,327 - Expenditure on: Costs of generating funds 5 28,253 - Charitable activities 6 45,860 - Governance costs 10 48 - Total resources expended 74,161 - Net income/(expenditure) for the year/net movement in funds 2,166 - Fund balances as at 1 May 2020 84,024 - Fund balances as at 30 April 2021 17 86,190 - Unrestricted funds |
Restricted funds 47,970 - - 47,970 - 30,000 - 30,000 17,970 22,278 40,248 |
2021 £ 123,118 1,138 41 124,297 28,253 75,860 48 104,161 20,136 106,302 126,438 |
2020 £ 94,353 - 113 |
|---|---|---|---|
| 94,466 20,276 64,938 78 |
|||
| 85,292 | |||
| 9,174 97,128 |
|||
| 106,302 |
The statement of financial activities includes all gains and losses recognised in the year
All income and expenditure relates to continuing activities.
The statement of financial activities also complies with the requirements of an income and expenditure account under the Companies Act 2006
The notes on pages 11 to 19 form part of these financial statements.
9
HEARTBURN CANCER UK BALANCE SHE Reoistered Nufflber 07227937 AS AT 30 APRIL 2021 2021 2020 Note 14 Fixed Assets 27,058 27,058 Current Assets Other debtors Cash at bank and in hand 7,203 92.735 99.938 9.999 100,819 110,818 Creditors: Amounts falling due within one year 16 15581 14,516J Net current assets 99,380 106,302 Total asset5 less current liabllitles 126.438 106,302 Net assets 126.438 106,302 Represented by: Intome Funds Restricted funds Unrestricted Funds Designated fund5 General unrestricted funds 17 40.248 22,278 17 17 86,190 84,024 126,438 106.302 The charitable company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006. for the year ended 30 April 2021. No member of the charitable company has deposited a notice, pursuant to secuon 476, requiring an audit of these financial statements. The Trustees acknowledge their responsibilities for complying with the reqirements of the Companies Act with respect to accounting records and the preparation of accounts. These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance wrth FRS102 SORP. These financial statements were approved by the Tmstees and authorised for i55ue on and are si8ned on their behalf by.. io zoZL Mrs M E Mccord Chair of Trustees The notes on pages 11 to 19 form part of these financial statements. io
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
1 Accounting policies
General information
Heartburn Cancer UK ("the charitable company") has prepared financial statements covering its results for the year to 30 April 2021. The charitable company has presented its financial statements in Sterling, rounded to the nearest whole pound.
The charitable company is a private company limited by guarantee and is incorporated in England and Wales. The address of the charitable company's registered office is presented on page 1 of these financial statements under Officers and Professional Advisors. The charitable company's principal activities and nature of the business are shown on page 2.
Basis of accounting
The financial statements have been prepared under the historical cost convention, in accordance with the charity's governing document, the Companies Act 2006, as applicable to companies subject to the small companies regime, "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("SORP") and with the Charities Act 2011. The principal accounting policies adopted are set out below.
The charity is a Public Benefit Entity as defined by FRS 102.
Statement of Cashflows
The charitable company has taken advantage of the provisions in the SORP for charities applying FRS102 update Bulletin 1 not to prepare a Statement of Cashflows.
Going concern
At the time of preparing the financial statements, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existance for the forseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
Charitable Funds
Unrestricted funds are available for use at the discretion of the Trustees in furtherence of their charitable objectives unless the funds have been designated, by the Trustees, for other purposes.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
Endowment funds are subject to specific conditions by donor that the capital must be maintained by the charity.
Incoming resources
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Donations by way of grants are recognised either on receipt or Invoice, whichever is earlier.
Donations and associated gift aid from on-line sites such as Just Giving and Virgin Giving are recognised as and when paid by those sites, after they have been verified and processed, and includes donations remitted to the charity from those sites within the financial year. These donations are recorded net of processing charges.
Other donations and legacies are recognised on receipt. Income tax recoverable in relation to donations received under Gift Aid is recognised at the time of the donation.
Donated services and facilities are included in the Statement of Financial Activities in the year they are received at the value of the gift to the charity, provided the value of the gift can be measured reliably. The expense element of such donations is reflected in resources expended in the appropriate expense category.
11
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
1 Accounting policies (continued)
Resources expended
Costs of generating voluntary income comprise the costs incurred by the charity to induce others to make donations to the charity.
Activities in furtherance of charitable objectives undertaken directly relate to expenditure incurred as a direct result of undertaking the charitable objectives of the charity.
Governance and core activities expenditure
Governance costs comprise all costs involving public accountability of the charity and its compliance with regulation and good practice.
Core Activities Expenditure are those costs incurred directly in support of the objects of the charitable company and fundraising and are allocated to activity cost categories on a basis consistent with the use of resources.
Tangible fixed assets
Tangible fixed assets are stated at cost less depreciation. Cost represents purchase price together with any incidental costs of acquisition.
Depreciation
Depreciation is calculated so as to write off the cost of an asset, net of anticipated disposal proceeds, over the useful economic life of that asset as follows:
- Mobile Diagnostic Unit straight line over 5 years
Financial Instruments
The charitable company only has financial assets and liabilites of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measure at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
Critical accounting estimates and areas of judgement
In the application of the charity's accounting policies, the Trustees are requried to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimated and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
12
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
| 2 Donations and legacies Unrestricted funds Donations and gifts 64,574 Donations in Kind 10,574 75,148 3 Fundraising activites Sale of Christmas Cards 4 Investments Interest receivable 5 Costs of generating funds Printing and advertising Website and social media Fund raising activities Other expenditure See note 8 for further details 6 Expenditure on Charitable Activities Unrestricted funds Grant funding of activities - Other expenditure 45,860 45,860 Analysis by fund for 2020 41,433 7 Grants payable Unrestricted funds HCUK East Anglia - To fund a surgical specialty lead - Other grants - - |
Designated funds - - - Designated funds - - - 2,500 Designated funds - - - - |
Restricted funds 47,970 - 47,970 Restricted funds 7,500 22,500 30,000 21,005 Restricted funds - 7,500 - 7,500 |
2021 £ 112,544 10,574 123,118 2021 £ 1,138 2021 £ 41 2021 £ 1,233 1,296 2,714 23,010 28,253 2021 £ 7,500 68,360 - 75,860 64,938 2021 £ - 7,500 - 7,500 |
2020 £ 84,309 10,044 |
|---|---|---|---|---|
| 94,353 | ||||
| 2020 £ - |
||||
| 2020 £ 113 |
||||
| 2020 £ 1,773 500 2,127 15,876 |
||||
| 20,276 | ||||
| 2020 £ 12,739 52,199 - |
||||
| 64,938 | ||||
| 2020 £ 239 7,500 5,000 |
||||
| 12,739 |
13
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
| 8 Core activities expenditure analysis for the year Fundraising Awareness Research Support Groups £ £ £ £ Staff costs 17,808 13,992 7,518 4,972 Travel costs and training 75 - - - Grants awarded - - 7,500 - Office space 3,539 2,780 1,494 988 Printing and advertising 1,233 11,098 - - Website and social media 1,296 11,666 - - IT and computer expenses 903 709 381 252 Postage, courier and telephone 184 144 78 51 Fundraising 2,714 - - - Office supplies 20 15 8 5 Insurance - - - - Bank charges 446 - - - Subscriptions - - - - Sundries - - - - Regulatory and governance costs 35 - - - 28,253 40,404 16,979 6,268 Total expended resources for the year to 30 April 2021 9 Allocation of costs to funds 2021 £ £ £ £ Unrestricted Designated Restricted Staff Costs 53,212 32,212 - 21,000 Travel costs 75 75 - - Grants awarded 7,500 - - 7,500 Office space 10,574 10,574 - - Printing and advertising 12,331 11,331 - 1,000 Website and social media 12,962 12,462 - 500 IT and computer expenses 2,697 2,697 - - Postage, courier and telephone 549 549 - - Fundraising 2,714 2,714 - - Office supplies 59 59 - - Insurance 444 444 - - Bank charges 590 590 - - Subscriptions 120 120 - - Sundries 286 286 - - Regulatory and governance costs 48 48 - - 104,161 74,161 - 30,000 2021 Allocation |
General support £ 8,922 - - 1,773 - - 452 92 - 11 444 144 120 286 13 |
|---|---|
| 12,257 | |
| 104,161 | |
| 2020 £ 32,653 668 12,739 10,858 17,732 4,998 1,003 1,191 2,127 104 444 276 125 246 128 |
|
| 85,292 |
Costs are allocated to funds on the basis of either actual costs incurred or estimated resource usage.
14
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
| 10 Governance Costs Legal and Professional fees Independent examiner's fee 11 Staff costs Salaries and wages Pension costs No staff receive more than £60,000 per annum. Average number of full time equivalent staff in the year Fundraising Charitable activities Other Average (absolute) number of staff in the year |
2021 £ 48 - 48 2021 £ 52,084 1,128 53,212 2021 FTE No 0.6 0.8 0.3 1.7 2021 No 3.0 |
2020 £ 48 30 |
|---|---|---|
| 78 | ||
| 2020 £ 32,157 496 |
||
| 32,653 | ||
| 2020 FTE No 0.4 0.5 0.2 |
||
| 1.1 | ||
| 2020 No 2.4 |
12 Trustees
None of the Trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.
15
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
13 Related Party Transactions
During the year Absolutely Offices Limited, of which Beryl Huntingdon, a trustee of the charitable company, is a director, provided the following services to the charity on normal commercial terms.
| Computer expenses Postage, courier and telephone Office supplies and sundry expenses Office space Printing and advertising |
2021 £ 196 - - 41 237 |
2020 £ - 873 120 814 - |
|---|---|---|
| 1,807 |
In addition, Absolutely Offices Limited provided the following services free of charge as a donation in kind:
| Office space Tangible fixed assets Cost At 1 May 2020 Additions At 30 April 2021 Depreciation At 1 May 2020 Charge for the period At 30 April 2021 Net book value At 30 April 2021 At 1 May 2020 |
2021 £ 10,044 10,044 £ - 27,058 27,058 - - - 27,058 - Mobile Diagnostic Unit |
2020 £ 10,044 |
|---|---|---|
| 10,044 | ||
| Total £ - 27,058 - |
||
| 27,058 | ||
| - - - |
||
| - | ||
| 27,058 | ||
| - |
14 Tangible fixed assets
16
HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
| 15 Other debtors Other debtors Prepayments and accrued income 16 Creditors: Amounts falling due within one year Trade creditor Other creditor - pension creditor Accruals and deferred income 17 Statement of Funds Unrestricted Funds Designated Funds General Funds Total unrestricted funds |
Balance at 1 May 2020 £ - - 84,024 84,024 |
2021 £ - 7,203 7,203 2021 £ 324 234 - 558 Incoming resources Resources expended Transfers £ £ £ - - - - - - 76,327 (74,161) - 76,327 (74,161) - Movement in Funds |
2020 £ 9,600 399 |
|---|---|---|---|
| 9,999 | |||
| 2020 £ 57 84 4,375 |
|||
| 4,516 | |||
| Balance at 30 April 2021 £ - |
|||
| - | |||
| 86,190 | |||
| 86,190 |
17
HEARTBURN CANCER UK
NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
17 Statement of Funds (continued)
| Restricted Funds HCUK Augis RCS Cytosponge Mobile Diagnostic Unit Staff Costs - Covid crisis period Return to fitness Awareness - North West of England Awareness - London Peer Support Network HCUK East Anglia Awareness |
Balance at 1 May 2020 £ 10,625 - 6,400 1,000 2,102 - - 2,151 - 22,278 |
Incoming resources Resources expended £ £ - (7,500) 31,370 14,600 (21,000) - - - - 500 - 500 (500) - - 1,000 (1,000) 47,970 (30,000) Movement in Funds |
Balance at 30 April 2021 £ 3,125 31,370 - 1,000 2,102 500 - 2,151 - |
|---|---|---|---|
| 40,248 |
HCUK Augis Royal College of Surgeons
To help fund a Surgical Speciality Lead in the field of Oesophageal Cancer
Cytosponge Mobile Diagnostic Unit
To fund the purchase of a Mobile Diagnostic Unit and related equipment, which are accounted for as fixed assets and will be depreciated from May 2021, and fund the running costs of the unit. The unit is currently being deployed to support the DELTA project to demonstrate the efficacy of the "Cytosponge" in promoting early diagnosis of Oesophageal Cancer and/or Barrett's Oesophagus.
Staff costs during the Covid Crisis period
To fund staff costs during the Covid crisis period.
Return to fitness
To support a research project into a programme to support Oesophageal Cancer patients recovering after treatment.
Awareness - North West of England
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus, in the North West of England.
Awareness- London
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus, in the London area.
Peer Support Network
To fund support networks for patients diagnosed with Oesophageal Cancer and/or Barrett's Oesophagus.
HCUK East Anglia
To fund the activities of the East Anglia support group with funds generated by the support group itself.
Awareness
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus.
18
HEARTBURN CANCER UK
NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2021
18 Analysis of net assets between funds
| Analysis of net assets between funds | |||
|---|---|---|---|
| Unrestricted funds Fund balances at 30 April 2021 are respresented by: Fixed Assets - Net current assets 86,190 Net assets 86,190 |
Designated funds - - - |
Restricted funds 27,058 13,190 40,248 |
Total £ 27,058 99,380 |
| 126,438 |
19 Ultimate controlling party
The trustees do not consider there to be an ultimate controlling party other than the Board of Trustees.
19